These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37357221)

  • 21. Idursulfase enzyme replacement therapy in an adult patient with severe Hunter syndrome having a novel mutation of iduronate-2-sulfatase gene.
    Christianto A; Watanabe H; Nakajima T; Inazu T
    Clin Chim Acta; 2013 Aug; 423():66-8. PubMed ID: 23726270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic analysis of 17 children with Hunter syndrome: identification and functional characterization of four novel mutations in the iduronate-2-sulfatase gene.
    Chistiakov DA; Kuzenkova LM; Savost'anov KV; Gevorkyan AK; Pushkov AA; Nikitin AG; Vashakmadze ND; Zhurkova NV; Podkletnova TV; Namazova-Baranova LS; Baranov AA
    J Genet Genomics; 2014 Apr; 41(4):197-203. PubMed ID: 24780617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Postnatal and prenatal diagnosis of mucopolysaccharidosis type II (Hunter syndrome)].
    Zhang WM; Shi HP; Li BT; Zhao SM; Qi QW; Sun NH; Huang SZ
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):644-7. PubMed ID: 17217652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in glycogen and glycosaminoglycan levels in hepatocytes of iduronate-2-sulfatase knockout mice before and after recombinant iduronate-2-sulfatase supplementation.
    Lee JH; Choe YH; Kim SJ; Paik KH; Jin DK
    Yonsei Med J; 2011 Mar; 52(2):263-7. PubMed ID: 21319344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations of the iduronate-2-sulfatase (IDS) gene in patients with Hunter syndrome (mucopolysaccharidosis II).
    Schröder W; Wulff K; Wehnert M; Seidlitz G; Herrmann FH
    Hum Mutat; 1994; 4(2):128-31. PubMed ID: 7981716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA.
    Wilson PJ; Morris CP; Anson DS; Occhiodoro T; Bielicki J; Clements PR; Hopwood JJ
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8531-5. PubMed ID: 2122463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of therapeutic iduronate-2-sulfatase enzyme with a novel single-stranded RNA virus vector.
    Ohira M; Kikuchi E; Mizuta S; Yoshida N; Onodera M; Nakanishi M; Okuyama T; Mashima R
    Genes Cells; 2021 Nov; 26(11):891-904. PubMed ID: 34480399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation analysis of the iduronate-2-sulfatase gene in patients with mucopolysaccharidosis type II (Hunter syndrome).
    Bunge S; Steglich C; Beck M; Rosenkranz W; Schwinger E; Hopwood JJ; Gal A
    Hum Mol Genet; 1992 Aug; 1(5):335-9. PubMed ID: 1303211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS.
    Tanaka N; Kida S; Kinoshita M; Morimoto H; Shibasaki T; Tachibana K; Yamamoto R
    Mol Genet Metab; 2018 Sep; 125(1-2):53-58. PubMed ID: 30064964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A close-up view of the Hunter syndrome.
    Ramírez CC; Alméciga-Díaz CJ; Martín-Rufián M; Cárdenas-García C; Espejo-Mojica AJ; Lobo C; Benincore EP
    Biochem Biophys Res Commun; 2024 Feb; 696():149490. PubMed ID: 38241811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iduronate-2-sulfatase transport vehicle rescues behavioral and skeletal phenotypes in a mouse model of Hunter syndrome.
    Arguello A; Meisner R; Thomsen ER; Nguyen HN; Ravi R; Simms J; Lo I; Speckart J; Holtzman J; Gill TM; Chan D; Cheng Y; Chiu CL; Dugas JC; Fang M; Lopez IA; Solanoy H; Tsogtbaatar B; Zhu Y; Bhalla A; Henne KR; Henry AG; Delucchi A; Costanzo S; Harris JM; Diaz D; Scearce-Levie K; Sanchez PE
    JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34622797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence of the human iduronate 2-sulfatase (IDS) gene.
    Wilson PJ; Meaney CA; Hopwood JJ; Morris CP
    Genomics; 1993 Sep; 17(3):773-5. PubMed ID: 8244397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for an iduronate-sulfatase pseudogene near the functional Hunter syndrome gene in Xq27.3-q28.
    Rathmann M; Bunge S; Steglich C; Schwinger E; Gal A
    Hum Genet; 1995 Jan; 95(1):34-8. PubMed ID: 7814022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IDS gene-pseudogene exchange responsible for an intragenic deletion in a Hunter patient.
    Birot AM; Bouton O; Froissart R; Maire I; Bozon D
    Hum Mutat; 1996; 8(1):44-50. PubMed ID: 8807335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease).
    Voznyi YV; Keulemans JL; van Diggelen OP
    J Inherit Metab Dis; 2001 Nov; 24(6):675-80. PubMed ID: 11768586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: Genetic, pathological, and structural studies on iduronate-2-sulfatase.
    Kosuga M; Mashima R; Hirakiyama A; Fuji N; Kumagai T; Seo JH; Nikaido M; Saito S; Ohno K; Sakuraba H; Okuyama T
    Mol Genet Metab; 2016 Jul; 118(3):190-197. PubMed ID: 27246110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational spectrum of the iduronate-2-sulfatase (IDS) gene in 36 unrelated Russian MPS II patients.
    Karsten S; Voskoboeva E; Tishkanina S; Pettersson U; Krasnopolskaja X; Bondeson ML
    Hum Genet; 1998 Dec; 103(6):732-5. PubMed ID: 9921913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of iduronate-2-sulfatase mRNA expression in Hunter syndrome (mucopolysaccharidosis type II).
    Crotty PL; Whitley CB
    Hum Genet; 1992 Nov; 90(3):285-8. PubMed ID: 1283150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucopolysaccharidosis type II in females and response to enzyme replacement therapy.
    Jurecka A; Krumina Z; Żuber Z; Różdżyńska-Świątkowska A; Kłoska A; Czartoryska B; Tylki-Szymańska A
    Am J Med Genet A; 2012 Feb; 158A(2):450-4. PubMed ID: 22246721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA deletion confined to the iduronate-2-sulfatase promoter abolishes IDS gene expression.
    Timms KM; Huckett LE; Belmont JW; Shapira SK; Gibbs RA
    Hum Mutat; 1998; 11(2):121-6. PubMed ID: 9482575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.